The expression of Nek7, FoxM1, and Plk1 in gallbladder cancer and their relationships to clinicopathologic features and survival.
about
Prognostic Value of FOXM1 in Patients with Malignant Solid Tumor: A Meta-Analysis and System ReviewPLK1, A Potential Target for Cancer Therapy"Stop Ne(c)king around": How interactomics contributes to functionally characterize Nek family kinasesC. elegans NIMA-related kinases NEKL-2 and NEKL-3 are required for the completion of molting.A Meta-Analysis of Retinoblastoma Copy Numbers Refines the List of Possible Driver Genes Involved in Tumor Progression.Risk prediction model for epithelial ovarian cancer using molecular markers and clinical characteristics.FOXM1 participates in PLK1-regulated cell cycle progression in renal cell cancer cells.Nek7 is overexpressed in hepatocellular carcinoma and promotes hepatocellular carcinoma cell proliferation in vitro and in vivoUse of a special Brazilian red-light emitting railroad worm Luciferase in bioassays of NEK7 protein Kinase and Creatine KinaseDown-regulation of FoxM1 inhibits viability and invasion of gallbladder carcinoma cells, partially dependent on inducement of cellular senescencep53-Dependent and cell specific epigenetic regulation of the polo-like kinases under oxidative stress.A 3'UTR polymorphism modulates mRNA stability of the oncogene and drug target Polo-like Kinase 1.NEK7 is required for G1 progression and procentriole formation.Conserved Ankyrin Repeat Proteins and Their NIMA Kinase Partners Regulate Extracellular Matrix Remodeling and Intracellular Trafficking in Caenorhabditis elegans.Downregulation of NIMA-related kinase-7 inhibits cell proliferation by inducing cell cycle arrest in human retinoblastoma cells.PLK1 expression and BI 2536 effects in childhood acute lymphoblastic leukemia.
P2860
Q26785676-7C02A830-0A81-4B4D-A126-F141750065A1Q28078772-58F84B57-6F6C-4001-9202-0A97A1FC6D66Q33728829-6C60838F-A82C-404E-9C11-3C3953D5D759Q35039941-E5C748C2-8B1D-498D-9547-B481732D0B70Q35999443-E88C4346-656A-426C-8461-007ED5CA11F0Q36199823-C5628151-B31C-4FFF-8D45-45DD14BCD851Q36741118-CF06BF60-0797-4B83-83A5-C2515AE58D15Q37109834-263D289A-458C-4106-A3B7-7D132006B208Q38671688-7C482B59-5E55-480B-A347-BF8D6E6DC0FDQ38970720-09DE9988-60D9-4EAA-B145-AFAF58BDB48CQ39027006-1E4E6FEE-FAC9-4FCD-8309-61E75FEC2BDAQ39599711-0D6F6A24-7EA9-4F75-9877-504945DEA8EEQ41662062-28B65AF2-4B57-467D-9D63-E507F4B02242Q46466764-32BE16EB-9F18-44B3-B7E3-EBF809D8BA93Q50054178-E260693A-EDBB-441C-AFDC-692051C7ECA8Q53066951-FE690E53-9EE5-4D68-AD27-D75A911375B5
P2860
The expression of Nek7, FoxM1, and Plk1 in gallbladder cancer and their relationships to clinicopathologic features and survival.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
The expression of Nek7, FoxM1, ...... hologic features and survival.
@en
The expression of Nek7, FoxM1, ...... hologic features and survival.
@nl
type
label
The expression of Nek7, FoxM1, ...... hologic features and survival.
@en
The expression of Nek7, FoxM1, ...... hologic features and survival.
@nl
prefLabel
The expression of Nek7, FoxM1, ...... hologic features and survival.
@en
The expression of Nek7, FoxM1, ...... hologic features and survival.
@nl
P2093
P2860
P1476
The expression of Nek7, FoxM1, ...... thologic features and survival
@en
P2093
P2860
P2888
P304
P356
10.1007/S12094-012-0978-9
P50
P577
2013-01-29T00:00:00Z